Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptin

Endocrine Practice

Volumn 17, Issue 5, 2011, Pages 819-825

  Chen, Lijun ^a   Philippe, Jacques ^b   Unger, Roger H ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; INTERMEDIN; LEPTIN; NEUROPEPTIDE Y; NEUROTENSIN; OREXIN; SOMATOSTATIN;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCAGON RELEASE; GLUCAGON SUPPRESSION; HAMSTER; HORMONAL REGULATION; HORMONE ACTION; HYPOTHALAMUS; IN VITRO STUDY; NONHUMAN; PANCREAS ISLET ALPHA CELL; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CRICETINAE; GLUCAGON; GLUCAGON-SECRETING CELLS; GLUCOSE; INSULIN; LEPTIN; MICE; RECEPTORS, LEPTIN; SOMATOSTATIN;

EID: 80054084629     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11101.OR     Document Type: Article

References (2)

1. Handelsman Y, Mechanick JI, Blonde L, et al; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(Suppl 2):1-53.
2. Handelsman Y, Mechanick JI, Blonde L, et al; AACE Task Force for Developing a Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: Executive sum-mary. Endocr Pract. 2011;17:287-302.